FullHope Biomedical Co (ROCO:7773) Cash Flow for Dividends: NT$0.00 Mil (TTM As of Dec. 2025)


ROCO:7773 FullHope Biomedical Co Ltd ROCO:7773
14 GF Score
Price NT$27.65
! 1 Warning Sign
View Full Analysis

What is FullHope Biomedical Co Cash Flow for Dividends?

FullHope Biomedical Co ROCO:7773 14 Cash Flow for Dividends is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:7773 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

FullHope Biomedical Co's cash flow for dividends for the six months ended in Dec. 2025 was NT$0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

FullHope Biomedical Co Cash Flow for Dividends Related Terms

FullHope Biomedical Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for FullHope Biomedical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FullHope Biomedical Co Cash Flow for Dividends Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
0.00 0.00 0.00 0.00 0.00

FullHope Biomedical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ROCO:7773
14GF Score
FullHope Biomedical Co Ltd ROCO:7773
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FullHope Biomedical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of NT$0.00 Mil mean?
FullHope Biomedical Co (ROCO:7773) has a Cash Flow for Dividends of NT$0.00 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for FullHope Biomedical Co and its competitors.
Is FullHope Biomedical Co's Cash Flow for Dividends too high?
FullHope Biomedical Co's current Cash Flow for Dividends is NT$0.00 Mil. Overall, FullHope Biomedical Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does FullHope Biomedical Co's Cash Flow for Dividends compare to VRTX and REGN?
FullHope Biomedical Co's Cash Flow for Dividends of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for FullHope Biomedical Co and its competitors. FullHope Biomedical Co's current Cash Flow for Dividends is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FullHope Biomedical Co stock overvalued right now?
FullHope Biomedical Co (ROCO:7773) has a current Cash Flow for Dividends of NT$0.00 Mil. The current Cash Flow for Dividends is NT$0.00 Mil. FullHope Biomedical Co's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For FullHope Biomedical Co (ROCO:7773), the current Cash Flow for Dividends is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FullHope Biomedical Co Business Description

Address Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
14GF Score

Get the complete analysis for ROCO:7773

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$27.65
Price